Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2017 4
2018 3
2020 1
2021 2
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Sanchez-Barradas
Page 1
Non-typeable Haemophilus influenzae and purpura fulminans.
Beechar VB, de la Flor C, Medford RJ. Beechar VB, et al. Among authors: de la flor c. BMJ Case Rep. 2020 Jul 8;13(7):e234880. doi: 10.1136/bcr-2020-234880. BMJ Case Rep. 2020. PMID: 32641317 Free PMC article. Review.
Cryopreservation modulates the detection of regulatory T cell markers.
Sattui S, de la Flor C, Sanchez C, Lewis D, Lopez G, Rizo-Patrón E, White AC Jr, Montes M. Sattui S, et al. Among authors: de la flor c. Cytometry B Clin Cytom. 2012 Jan;82(1):54-8. doi: 10.1002/cyto.b.20621. Epub 2011 Sep 20. Cytometry B Clin Cytom. 2012. PMID: 21936048 Free article.
What's in a name? The heterogeneous clinical spectrum and prognostic factors in a cohort of adults with hemophagocytic lymphohistiocytosis.
Prokesch BC, Nagalla S, Ezzati F, Tujios SR, Dominguez A, Chen W, Kershaw C, Patel P, de la Flor C, Foster J, Martin AA, de la Morena MT, Wysocki CA. Prokesch BC, et al. Among authors: de la flor c. Transfus Apher Sci. 2018 Dec;57(6):779-784. doi: 10.1016/j.transci.2018.10.001. Epub 2018 Oct 6. Transfus Apher Sci. 2018. PMID: 30327177
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Kremsner PG, Ahuad Guerrero RA, Arana-Arri E, Aroca Martinez GJ, Bonten M, Chandler R, Corral G, De Block EJL, Ecker L, Gabor JJ, Garcia Lopez CA, Gonzales L, Granados González MA, Gorini N, Grobusch MP, Hrabar AD, Junker H, Kimura A, Lanata CF, Lehmann C, Leroux-Roels I, Mann P, Martinez-Reséndez MF, Ochoa TJ, Poy CA, Reyes Fentanes MJ, Rivera Mejia LM, Ruiz Herrera VV, Sáez-Llorens X, Schönborn-Kellenberger O, Schunk M, Sierra Garcia A, Vergara I, Verstraeten T, Vico M, Oostvogels L; HERALD Study Group. Kremsner PG, et al. Lancet Infect Dis. 2022 Mar;22(3):329-340. doi: 10.1016/S1473-3099(21)00677-0. Epub 2021 Nov 23. Lancet Infect Dis. 2022. PMID: 34826381 Free PMC article. Clinical Trial.
13 results